<DOC>
	<DOC>NCT02568735</DOC>
	<brief_summary>The main purpose of this study was to determine the plasma and central nervious system pharmacokinetics of dexketoprofen and etoricoxib. The secondary aim was to asses their effect on the concentrations of interleukin 6, prostaglandin E2 and other proinflammatory markers both in plasma and cerebrospinal fluid. Thirdly, the investigators aimed to evaluate their efficacy in postoperative pain treatment.</brief_summary>
	<brief_title>Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>agreed to participate the study American Society of Anesthesiologist s physical status classification 13 elective hip arthroplasty planned no contraindications to the study drugs no contraindication to lumbar puncture refused to participate the study age less than 40 or over 75 years Planned anesthesia method other than spinal anesthesia contraindications to the study drugs Contraindications to lumbar puncture</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Dexketoprofen</keyword>
	<keyword>Etoricoxib</keyword>
	<keyword>hip arthroplasty</keyword>
	<keyword>pain</keyword>
</DOC>